X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (29) 29
index medicus (29) 29
endocrinology & metabolism (16) 16
male (16) 16
obesity (16) 16
digestive, oral, and skin physiology (15) 15
humans (14) 14
mice (14) 14
food-intake (13) 13
rats (12) 12
ghrelin - metabolism (11) 11
hormones, hormone substitutes, and hormone antagonists (11) 11
abridged index medicus (10) 10
metabolism (9) 9
glucose (8) 8
hormone secretagogue receptor (8) 8
insulin (8) 8
mice, knockout (8) 8
body weight (7) 7
body-weight (7) 7
eating - drug effects (7) 7
endocrine system (7) 7
endocrinology (7) 7
ghrelin (7) 7
obesity - metabolism (7) 7
physiological aspects (7) 7
diabetes (6) 6
energy metabolism - drug effects (6) 6
energy-balance (6) 6
female (6) 6
ghrelin - pharmacology (6) 6
receptors, ghrelin - metabolism (6) 6
research (6) 6
acylation (5) 5
acyltransferases - metabolism (5) 5
analysis (5) 5
arcuate nucleus (5) 5
article (5) 5
care and treatment (5) 5
eating - physiology (5) 5
glucagon (5) 5
glucagon-like peptide-1 receptor (5) 5
glucose - metabolism (5) 5
glucose tolerance test (5) 5
mice, inbred c57bl (5) 5
rats, long-evans (5) 5
receptors, glucagon - agonists (5) 5
receptors, glucagon - metabolism (5) 5
unacylated ghrelin (5) 5
acyltransferases - genetics (4) 4
adiposity (4) 4
blood glucose - metabolism (4) 4
body composition - drug effects (4) 4
body weight - drug effects (4) 4
diet, high-fat (4) 4
eating (4) 4
energy metabolism - physiology (4) 4
glucose metabolism (4) 4
homeostasis (4) 4
hormones (4) 4
insulin - metabolism (4) 4
insulin-resistance (4) 4
peptide (4) 4
receptors, glucagon - genetics (4) 4
rodents (4) 4
signal transduction - drug effects (4) 4
adipose tissue, brown - metabolism (3) 3
animal models (3) 3
beta-cells (3) 3
biology (3) 3
body composition (3) 3
brain - metabolism (3) 3
brown adipose-tissue (3) 3
cell biology (3) 3
circulating ghrelin (3) 3
des-acyl ghrelin (3) 3
diabetes mellitus (3) 3
energy metabolism (3) 3
feeding behavior - drug effects (3) 3
fibroblast growth factors (3) 3
genetic aspects (3) 3
ghrelin - administration & dosage (3) 3
ghrelin - blood (3) 3
glp-1 (3) 3
glucagon - metabolism (3) 3
glucagon-like peptide 1 - metabolism (3) 3
glucagon-like peptide-1 (3) 3
growth-hormone (3) 3
health aspects (3) 3
infusions, intraventricular (3) 3
insulin resistance (3) 3
insulin-secretion (3) 3
liraglutide (3) 3
models, biological (3) 3
multidisciplinary sciences (3) 3
neuropeptide-y (3) 3
neurosciences (3) 3
obesity - drug therapy (3) 3
original research (3) 3
peptides (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Endocrinology, ISSN 0804-4643, 2014, Volume 171, Issue 1, pp. R21 - R32
Journal Article
Journal Article
Frontiers in Neuroscience, ISSN 1662-4548, 03/2015, Volume 9
Journal Article
Journal Article
Diabetes, ISSN 0012-1797, 11/2012, Volume 61, Issue 11, pp. 2753 - 2762
Journal Article
Diabetes, ISSN 0012-1797, 05/2013, Volume 62, Issue 5, pp. 1453 - 1463
Glucagon, an essential regulator of glucose homeostasis, also modulates lipid metabolism and promotes weight loss, as reflected by the wasting observed in... 
PPAR-ALPHA | BODY-WEIGHT | METABOLISM | FIBROBLAST-GROWTH-FACTOR-21 | PHARMACOLOGY | INCREASES ENERGY-EXPENDITURE | ENDOCRINOLOGY & METABOLISM | DEGRADATION | MICE | INSULIN SENSITIVITY | FGF21 | Obesity - drug therapy | Humans | Peptides - pharmacokinetics | Fibroblast Growth Factors - genetics | Male | Fibroblast Growth Factors - secretion | Obesity - blood | Anti-Obesity Agents - therapeutic use | Glucagon - agonists | Fibroblast Growth Factors - metabolism | Anti-Obesity Agents - pharmacokinetics | Peptides - chemical synthesis | Hepatocytes - secretion | Hypoglycemic Agents - therapeutic use | Receptors, Glucagon - agonists | Receptors, Glucagon - genetics | Hypoglycemic Agents - pharmacokinetics | Peptides - physiology | Rats | Hypoglycemic Agents - pharmacology | Mice, Knockout | Cross-Over Studies | Anti-Obesity Agents - chemical synthesis | Mice | Anti-Obesity Agents - pharmacology | Hepatocytes - pathology | Diabetes Mellitus, Type 2 - metabolism | Hepatocytes - metabolism | Molecular Targeted Therapy | Mice, Mutant Strains | HEK293 Cells | Adult | Female | Hepatocytes - drug effects | Recombinant Proteins - metabolism | Double-Blind Method | Cells, Cultured | Insulin Resistance | Receptors, Glucagon - metabolism | Recombinant Proteins - agonists | Glucagon - pharmacology | Obesity - metabolism | Diabetes Mellitus, Type 2 - blood | Animals | Fibroblast Growth Factors - blood | Hypoglycemic Agents - chemical synthesis | Glucagon - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Peptides - therapeutic use | Physiological aspects | Fibroblast growth factors | Research | Glucagon | Analysis | Original Research
Journal Article
PLoS ONE, ISSN 1932-6203, 2012, Volume 7, Issue 2, p. e32100
Journal Article
European journal of endocrinology / European Federation of Endocrine Societies, ISSN 0804-4643, 2014, Volume 171, Issue 1, pp. R21 - 32
Journal Article
International Journal of Obesity, ISSN 0307-0565, 06/2018, Volume 42, Issue 6, pp. 1151 - 1160
Objective Administration of FGF21 and FGF21 analogues reduce body weight; improve insulin sensitivity and dyslipidemia in animal models of obesity and in short... 
NONHUMAN-PRIMATES | NUTRITION & DIETETICS | LONG-ACTING FGF21 | ENERGY-EXPENDITURE | PF-05231023 | INSULIN-RESISTANCE | ENDOCRINOLOGY & METABOLISM | ENHANCED EFFICACY | MICE | EXPRESSION | GROWTH-FACTOR 21 | CORTISOL | Glucose Tolerance Test | Anti-Obesity Agents - administration & dosage | Obesity - drug therapy | Blood Glucose | Fibroblast Growth Factors - pharmacology | Macaca mulatta | Weight Loss - drug effects | Eating - physiology | Obesity - metabolism | Dose-Response Relationship, Drug | Eating - drug effects | Bone Density - drug effects | Animals | Fibroblast Growth Factors - administration & dosage | Diet, High-Fat | Weight Loss - physiology | Energy Metabolism - physiology | Hydrocortisone - blood | Anti-Obesity Agents - pharmacology | Energy Metabolism - drug effects | Disease Models, Animal | Obesity | Care and treatment | Physiological aspects | Models | Fibroblast growth factors | Health aspects | Ketogenic diet | Lipoproteins (low density) | Animal models | Body weight | Dyslipidemia | Clinical trials | Lipids | Monkeys | Hormones | Glucose | Males | Drug development | Hydrocortisone | Density | Composition effects | Body composition | High fat diet | Bone resorption | Glucose metabolism | Body composition (biology) | Bone density | Lipid metabolism | Bone composition | Food | Dual energy X-ray absorptiometry | Medical research | Ovariectomy | Diabetes mellitus | Markers | Triglycerides | Metabolism | Insulin | Cholesterol | Bone mineral content | Glucose tolerance | Organic chemistry | Sensitivity | Side effects | Food intake | Collagen | Weight reduction | Bone mineral density | Females
Journal Article
European Journal of Endocrinology, ISSN 0804-4643, 07/2010, Volume 163, Issue 1, pp. 1 - 8
Journal Article
Frontiers in neuroscience, ISSN 1662-4548, 2015, Volume 9, p. 92
Glucagon-like peptide-1 (GLP-1) enhances meal-related insulin secretion, which lowers blood glucose excursions. In addition to its incretin action, GLP-1 acts... 
Journal Article
Journal Article